214665 Finsbury WWP pp59-BC 6 15 09 1:51 PM Page 61 Finsbury Worldwide Pharmaceutical Trust PLC Annual Report 2009 61 Company Information DIRECTORS REGISTRARS CONTINUED Martin Smith Chairman Please contact the Registrars if you have a query about a Josephine Dixon certificated holding in the Companys shares.
Paul Gaunt calls cost 10p per minute plus network charges and may be recorded for Professor Duncan Geddes training purposes.
Dr David Holbrook Samuel D Isaly STOCKBROKER Anthony Townsend Winterflood Securities Limited COMPANY REGISTRATION NUMBER The Atrium Building 3023689 Registered in England Cannon Bridge, 25 Dowgate Hill The Company is an investment company as defined under London EC4R 2GA Section 833 of the Companies Act 2006 WEBSITE ALLIANCE TRUST SAVINGS LIMITED Website: www.
com PO Box 164 Meadow House REGISTERED OFFICE 64 Reform Street One Wood Street Dundee London EC2V 7WS DD1 9YP MANAGER, ADMINISTRATOR AND COMPANY Customer Services: 01382 573737 SECRETARY E-mail: contact@alliancetrust.
Frostrow Capital LLP Please contact Alliance Trust Savings Limited if 25 Southampton Buildings, London WC2A 1AL Telephone: 0203 008 4910 you have a query concerning an Alliance Trust E-mail: info@frostrow.
com Savings Scheme, First Steps Plan or ISA account.
com Calls to this number are recorded for monitoring purposes only and will be Authorised and regulated by the Financial Services Authority charged at local rates, non-BT line charges may vary.
If you have an enquiry about the Company or if you would like to SHARE AND WARRANT PRICE LISTINGS receive a copy of the Companys monthly fact sheet by e-mail, The price of your shares and warrants can be found in various please contact Frostrow Capital using the above e-mail address.
publications including the Financial Times, The Daily Telegraph, INVESTMENT MANAGER The Times, The Scotsman and The Herald.
OrbiMed Capital LLC 767 Third Avenue, 30th Floor The Companys net asset value per share is announced daily New York NY10017 - 2023 and is available, together with the share price, on the TrustNet Website: www.
com Registered under the US Securities & Exchange Commission AUDITORS IDENTIFICATION CODES Ernst & Young LLP Shares: SEDOL : 0338530 1 More London Place ISIN : GB0003385308 London SE1 2AF BLOOMBERG : FWP LN EPIC : FWP REGISTRARS Warrants: SEDOL : 8038453 Capita Registrars ISIN : GB0080384537 Northern House, Woodsome Park BLOOMBERG : FWPW LN Fenay Bridge, Huddersfield West Yorkshire HD8 0LA Telephone in UK : 0871 664 0300 Telephone from overseas : 44 208 639 3399 Facsimile: 44 0 1484 600911 E-mail: ssd@capitaregistrars.
com DISABILITY ACT Copies of this annual report and other documents issued by the Company are available from the Company Secretary.
If needed, copies can be made available in a variety of formats, including Braille, audio tape or larger type as appropriate.
You can contact the Registrar to the Company, Capita Registrars, which has installed telephones to allow speech and hearing impaired people who have their own telephone to contact them directly, without the need for an intermediate operator, for this service please call 0800 731 1888.
Specially trained operators are available during normal business hours to answer queries via this service.
Alternatively, if you prefer to go through a typetalk operator provided by the RNID you should dial 18001 followed by the number you wish to dial.
214665 Finsbury WWP pp59-BC 6 15 09 1:51 PM Page 62 Finsbury Worldwide Pharmaceutical Trust PLC Annual Report 2009 62 Past performance is not a guide to future performance.
Changes in the rates of exchange between currencies may cause the value of investments to fluctuate.
Fluctuation may be particularly marked in the case of a higher volatility fund and the value of an investment may fall suddenly and substantially.
When investing in shares in the pharmaceutical and biotechnology sectors it is important to note that shares in these sectors can be particularly volatile.
The price of shares and any income from them may fall as well as rise and is not guaranteed.
The investor may not get back the original amount invested.
This document does not constitute an offer or invitation to purchase shares in the Company.
214665 Finsbury WWP pp59-BC 6 15 09 1:51 PM Page 63 Finsbury Worldwide Pharmaceutical Trust PLC Annual Report 2009 63 This report is printed on Revive 75 Silk.
The paper consists of 50% fide-inked post consumer waste, 25% pre-consumer waste and 25% virgin wood fibre.
The pulp used is a combination of Elemental Chlorine Free ECF and Totally Chlorine Free TCF.
The mill is certified to environmental management standard ISO 14001.
This product has been awarded the NAPM 75% Recycled Mark.
This report has been printed using vegetable based inks.
FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2009 214665 Finsbury WWP Cover 6 15 09 1:56 PM Page 1 2009 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2009 Finsbury Worldwide Pharmaceutical Trust PLC 25 Southampton Buildings, London WC2A 1AL www.
